Radiosensitization Effects by Bismuth Oxide Nanoparticles in Combination with Cisplatin for High Dose Rate Brachytherapy

References

• International Atomic Energy Agency (IAEA). Radiotherapy in cancer care: facing the global challenge; 2017 Available from: https://www-pub.iaea.org/MTCD/Publications/PDF/P1638_web.pdf. Accessed 129, 2019.
   Google Scholar
• Rahman WNWA. Gold nanoparticles: novel radiobiological dose enhancement studies for radiation therapy, synchrotron based microbeam and stereotactic radiotherapy [dissertation]. PhD. RMIT University; 2010.
   Google Scholar
• Mukherjee A, Patra NB, Manir KS, Shyamal KS. A prospective clinical study on the benefit of adding chemotherapy to brachytherapy in patients with incomplete response to external beam irradiation with concurrent chemotherapy in locally advanced cases of carcinoma cervix. Indian J Med Res Pharm Sci. 2016;3(7):9–19. doi:10.5281/zenodo.1019549
   Google Scholar
• Aghili M, Andalib B, Moghaddam ZK, Safaie M, Hashemi FA, Darzikolaie NM. Concurrent chemo- radiobrachytherapy with cisplatin and medium dose rate intra- cavitary brachytherapy for locally advanced uterine cervical cancer. Asian Pacific J Cancer Prev. 2018;19:2745–2750. doi:10.22034/APJCP.2018.19.10.2745
   PubMedGoogle Scholar
• Chandel SS, Jain RK. Evaluation of role of radical radiotherapy and chemotherapy in cervical cancer patients- A preliminary report. Clin Cancer Investig J. 2016;2(5):126–131. doi:10.4103/2278-0513.177127
   Google Scholar
• Amouzegar-Hashemi F, Akbari EH, Esmati E. Concurrent chemoradiation with weekly gemcitabine and cisplatin for locally advanced cervical cancer. Asian Pacific J Cancer Prev. 2013;14:5385–5389. doi:10.7314/apjcp.2016.17.s3.287
   PubMedGoogle Scholar
• Cui L, Her S, Dunne M, et al. Significant radiation enhancement effects by gold nanoparticles in combination with cisplatin in triple negative breast cancer cells and tumor xenografts. Radiat Res. 2017;187(2):147–160. doi:10.1667/RR14578.128085639
   PubMed Web of Science ®Google Scholar
• Cho S, Jeong JH, Kim CH, Yoon M. Monte Carlo simulation study on dose enhancement by gold nanoparticles in brachytherapy. J Korean Phys Soc. 2010;56(6):1754–1758. doi:10.3938/jkps.56.1754
   Web of Science ®Google Scholar
• Gupta S, Koru-Sengul T, Arnold SM, Devi GR, Mohiuddin M, Ahmed MM. Low-dose fractionated radiation potentiates the effects of cisplatin independent of the hyper-radiation sensitivity in human lung cancer cells. Mol Cancer Ther. 2011;10(2):292–302. doi:10.1158/1535-7163.mct-10-063021216938
   PubMed Web of Science ®Google Scholar
• Cui L Optimization of gold nanoparticle radiosensitizers for cancer therapy optimization of gold nanoparticle radiosensitizers [dissertation]. PhD. University of Toronto; 2016.
   Google Scholar
• Rahman WN, Corde S, Yagi N, Abdul Aziz SA, Annabell N, Geso M. Optimal energy for cell radiosensitivity enhancement by gold nanoparticles using synchrotron-based monoenergetic photon beams. Int J Nanomedicine. 2014;9(1):2459–2467. doi:10.2147/IJN.S5947124899803
   PubMedGoogle Scholar
• Lazim RM, Rashid RA, Pham BTT, Hawkett BS, Geso M, Rahman WN. Radiation dose enhancement effects of superparamagnetic iron oxide nanoparticles to the T24 bladder cancer cell lines irradiated with megavoltage photon beam radiotheray. J Sains Nukl Malaysia. 2018;30(2):30–38.
   Google Scholar
• Abdul Rashid R, Zainal Abidin S, Khairil Anuar MA, et al. Radiosensitization effects and ROS generation by high Z metallic nanoparticles on human colon carcinoma cell (HCT116) irradiated under 150 MeV proton beam. OpenNano. 2019;4:100027. doi:10.1016/j.onano.2018.100027
   Google Scholar
• Yang C, Bromma K, Sung W, Schuemann J, Chithrani D. Determining the radiation enhancement effects of gold nanoparticles in cells in a combined treatment with cisplatin and radiation at therapeutic megavoltage energies. Cancers (Basel). 2018;10(150):1–16. doi:10.3390/cancers10050150
   Google Scholar
• Taha E, Djouider F, Banoqitah E. Monte Carlo simulations for dose enhancement in cancer treatment using bismuth oxide nanoparticles implanted in brain soft tissue. Australas Phys Eng Sci Med. 2018;41:363–370. doi:10.1007/s13246-018-0633-z29582243
   PubMed Web of Science ®Google Scholar
• Stewart C, Konstantinov K, McKinnon S, et al. First proof of bismuth oxide nanoparticles as efficient radiosensitisers on highly radioresistant cancer cells. Phys Medica. 2016;32:11. doi:10.1016/j.ejmp.2016.10.015
   Web of Science ®Google Scholar
• Stewart CAC An investigation into the tailoring of bismuth oxide nanoceramic with a biomedical application as a high Z radiation enhancer for cancer therapy [dissertation]. Master of Science. University of Wollongong; 2014.
   Google Scholar
• Ovsyannikov VA, Zamoryanskaya MV, Semencha AV, et al. Development of bismuth oxide-based nanopreparation for the destruction of malignant neoplasms: theoretical prerequisites, challenges, and practical approaches. Glas Phys Chem. 2015;41(5):533–536. doi:10.1134/S1087659615050119
   Web of Science ®Google Scholar
• Zulkifli ZA, Razak KA, Rahman WNWA, Abidin SZ. Synthesis and characterisation of bismuth oxide nanoparticles using hydrothermal method: the effect of reactant concentrations and application in radiotherapy. J Phys Conf Ser. 2018;1082:1. doi:10.1088/1742-6596/1082/1/012103
   Google Scholar
• Alqathami M, Blencowe A, Geso M, Ibbott G. Quantitative 3D determination of radiosensitization by bismuth-based nanoparticles. J Biomed Nanotechnol. 2016;12(3):464–471. doi:10.1166/jbn.2016.218327280244
   PubMed Web of Science ®Google Scholar
• Hubbell JH, Seltzer SM. X-ray mass attenuation coefficients. NIST Standard Reference Database 126. 2004; Available from: http://www.nist.gov/pml/x-ray-mass-attenuationcoefficients. Accessed March 18, 2019.
   Google Scholar
• Nor NAM, Mohd Z, Razak HRA, Eshak Z, Saad WMM. Synthetisation temperature-dependent cytotoxicity of bismuth oxide nanoparticles in vitro. Pertanika J Sci Technol. 2017;25(S):227–236.
   Google Scholar
• Ahamed M, Akhtar MJ, Khan MAM, Alrokayan SA, Alhadlaq HA. Oxidative stress mediated cytotoxicity and apoptosis response of bismuth oxide (Bi2O3) nanoparticles in human breast cancer (MCF-7) cells. Chemosphere. 2019;216:823–831. doi:10.1016/j.chemosphere.2018.10.21430399561
   PubMed Web of Science ®Google Scholar
• Feoktistova M, Geserick P, Leverkus M. Crystal violet assay for determining viability of cultured cells. Cold Spring Harb Protoc. 2016;2016(4):343–346. doi:10.1101/pdb.prot087379
   Google Scholar
• Sisin NNT, Abidin SZ, Yunus MA, Zin HM, Razak KA, Rahman WN. Evaluation of bismuth oxide nanoparticles as radiosensitizer for megavoltage. Int J Adv Sci Eng Inf Technol. 2019;9(4):1434–1443. doi:10.18517/ijaseit.9.4.7218
   Google Scholar
• Passagne I, Morille M, Rousset M, Pujalté I, L’Azou B. Implication of oxidative stress in size-dependent toxicity of silica nanoparticles in kidney cells. Toxicology. 2012;299(2–3):112–124. doi:10.1016/j.tox.2012.05.01022627296
   PubMed Web of Science ®Google Scholar
• Kim TH, Kim M, Park HS, Shin US, Gong MS, Kim HW. Size-dependent cellular toxicity of silver nanoparticles. J Biomed Mater Res Part A. 2012;100A:1033-1043. doi:10.1002/jbm.a.34053
   Web of Science ®Google Scholar
• Boo L, Ho WY, Ali NM, et al. Phenotypic and microRNA transcriptomic profiling of the MDA-MB-231 spheroid- enriched CSCs with comparison of MCF- 7 microRNA profiling dataset. PeerJ. 2017;5(e3551):1–27. doi:10.7717/peerj.3551
   Google Scholar
• Carraher CE, Michael J, Ryan RR, Lindsey AM, Kendra M, Floyd B. Synthesis and preliminary cancer cell line results for the product of organotin dihalides and alpha-cyano-4-hydroxycinnamic acid. J Inorg Organomet Polym Mater. 2016;1–11. doi:10.1007/s10904-016-0363-1
   Web of Science ®Google Scholar
• Eblan MJ, Wang AZ. Improving chemoradiotherapy with nanoparticle therapeutics. Transl Cancer Res. 2013;2(4):320–329. doi:10.3978/j.issn.2218-676X.2013.08.0425429359
   PubMedGoogle Scholar
• Ghosh P, Singh A, Roy S, Basu A, Bhattacharjee A, Bhattacharya S. Sensitization of cisplatin therapy by a naphthalimide based organoselenium compound through modulation of antioxidant enzymes and p53 mediated apoptosis. Free Radic Res. 2015;49(4):453–471. doi:10.3109/10715762.2015.101207925730340
   PubMed Web of Science ®Google Scholar
• Roeske JC, Nuñez L, Hoggarth M, Labay E, Weichselbaum RR. Characterization of the theorectical radiation dose enhancement from nanoparticles. Technol Cancer Res Treat. 2007;6(5):395–401. doi:10.1177/15330346070060050417877427
   PubMed Web of Science ®Google Scholar
• Brun E, Sicard-Roselli C. Actual questions raised by nanoparticle radiosensitization. Radiat Phys Chem. 2016;128:134–142. doi:10.1016/j.radphyschem.2016.05.024
   Web of Science ®Google Scholar
• Gray M, Turnbull AK, Ward C, et al. Development and characterisation of acquired radioresistant breast cancer cell lines. Radiat Oncol. 2019;14(1):1–19. doi:10.1186/s13014-019-1268-230621744
   PubMedGoogle Scholar
• Dinkelborg PH, Wang M, Gheorghiu L, et al. A common Chk1-dependent phenotype of DNA double-strand break suppression in two distinct radioresistant cancer types. Breast Cancer Res Treat. 2019;174(3):605–613. doi:10.1007/s10549-018-05079-730607635
   PubMedGoogle Scholar
• Phillips TM, McBride WH, Pajonk F. The response of CD24-/low/CD44+ breast cancer-initiating cells to radiation. J Natl Cancer Inst. 2006;98(24):1777–1785. doi:10.1093/jnci/djj49517179479
   PubMedGoogle Scholar
• Aghili M, Andalib B, Hashemi FA, et al. Concurrent chemo-brachytherapy with cisplatin and intracavitary brachytherapy in locally advanced uterine cervical cancer. CANCER Bull Cancer Inst Iran. 2010;2:45–52.
   Google Scholar
• Corde S, Joubert A, Adam JF, et al. Synchrotron radiation-based experimental determination of the optimal energy for cell radiotoxicity enhancement following photoelectric effect on stable iodinated compounds. Br J Cancer. 2004;91(3):544–551. doi:10.1038/sj.bjc.660195115266326
   PubMed Web of Science ®Google Scholar
• Tong L, Chuang C, Wu S, Zuo L. Reactive oxygen species in redox cancer therapy. Cancer Lett. 2015;07:008. doi:10.1016/j.canlet.2015.07.008
   Google Scholar
• Vlashi E, Pajonk F. Cancer stem cells, cancer cell plasticity and radiation therapy. Semin Cancer Biol. 2015;31:28–35. doi:10.1016/j.semcancer.2014.07.001.Cancer25025713
   PubMed Web of Science ®Google Scholar
• Saeidnia S, Abdollahi M. Antioxidants: friends or foe in prevention or treatment of cancer: the debate of the century. Toxicol Appl Pharmacol. 2013;271:49–63. doi:10.1016/j.taap.2013.05.00423680455
   PubMed Web of Science ®Google Scholar
• Sai S, Shirai T, Kamada T. Effects of carbon ion beam alone or in combination with Chk1 inhibitor and gemcitabine on putative pancreatic cancer stem cells. Pancreatology. 2013;13(4):S2. doi:10.1016/j.pan.2013.07.066
   Google Scholar
• Cheng K, Sano M, Jenkins CH, Zhang G, Vernekohl D. Synergistically enhancing therapeutic effect of radiation therapy with radiation activatable and reactive oxygen species-releasing nanostructures. ACS Nano. 2018;12(5):4946–4958. doi:10.1021/acsnano.8b0203829689158
   PubMed Web of Science ®Google Scholar
• Stewart C, Konstantinov K, McDonald M, et al. Engineering of bismuth oxide nanoparticles to induce differential biochemical activity in malignant and nonmalignant cells. Part Part Syst Charact. 2014;31(9):960–964. doi:10.1002/ppsc.201300380
   Web of Science ®Google Scholar
• Kirkova M, Alexandrova A, Yordanova N. Bismuth increases hydroxyl radical-scavenging activity of histamine H2-receptor antagonists. Pharmacol Rep. 2006;58(2):215–220.16702623
   PubMed Web of Science ®Google Scholar
• Turkez H, Geyikoglu F. The efficiacy of bismuth subnitrate against genotoxicity and oxidative stress induced by aluminum sulphate. Toxicol Ind Health. 2011;27(2):133–142. doi:10.1177/074823371038189420823050
   PubMedGoogle Scholar
• Zhang XD, Jing Y, Song S, et al. Catalytic topological insulator Bi2Se3 nanoparticles for in vivo protection against ionizing radiation. Nanomed Nanotechnol Biol Med. 2017;13(5):1597–1605. doi:10.1016/j.nano.2017.02.018
   PubMed Web of Science ®Google Scholar
• Shakibaie M, Amiri-Moghadam P, Ghazanfari M, Adeli-Sardou M, Jafari M, Forootanfar H. Cytotoxic and antioxidant activity of the biogenic bismuth nanoparticles produced by Delftia sp. SFG. Mater Res Bull. 2018;104:155–163. doi:10.1016/j.materresbull.2018.04.001
   Web of Science ®Google Scholar
• Baskar R, Lee KA, Yeo R, Yeoh K-W. Cancer and radiation therapy: current advances and future directions. Int J Med Sci. 2012;9(3):193–199. doi:10.7150/ijms.363522408567
   PubMed Web of Science ®Google Scholar
• Martins I, Raza SQ, Voisin L, et al. Anticancer chemotherapy and radiotherapy trigger both non-cell-autonomous and cell-autonomous death article. Cell Death Dis. 2018;9:7. doi:10.1038/s41419-018-0747-y29311672
   PubMedGoogle Scholar